Figure 3
![Figure 3. Inhibition of tumor relapse by syngeneic anti–third-party Tcm after syngeneic BMT. Lethally irradiated (8Gy TBI) BALB/c mice (H-2d) received an intravenous transplant of 3 × 106 syngeneic T-depleted BM cells (BALB/c nude [H-2d]) in the presence or absence of 5 × 103A20-luc lymphoma cells (day 0). On the following day, mice were intravenously injected with 10 × 106 (n = 7) or 2 × 107 (n = 5) BALB/c-derived anti–third-party Tcm or left untreated (A20 only) (n = 7). (A) Tumor growth was monitored by BLI from day 14 at weekly intervals. (B) Survival curves of the animals from the various treatment groups are shown.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/121/15/10.1182_blood-2012-06-432443/4/3033f3.jpeg?Expires=1724253586&Signature=RYrWiMyXwd~J8gV-u3a84vtKSIXVItdoDm5Y7N4cEi01Np7I6ji4vF6WjiYYWDFGREQOd52QLPpmCFNrQUpc-c6-E4RbJlj8aERpYxyWlGPPK5lMvtPPWekgfHKgURqgdY1Tio9xBQX7GlFlkt-1MCtOkF5B7aKmXHek43jORZgCensZinPOuB5kiDh4UcFU~1JHGOusJWsDuChxZX6vhC6mrvuqLyFg7JCOW2ibOgx2eEVvyX9gfxCe073hCmdtmhcTSiJyN4frtImp2fYWbmDE7~qfjPmU~YmP866PCl5dUQwTVS8-x9qG0vu4JSQGojahb1h6Q6uZTVT4eVfA4w__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Inhibition of tumor relapse by syngeneic anti–third-party Tcm after syngeneic BMT. Lethally irradiated (8Gy TBI) BALB/c mice (H-2d) received an intravenous transplant of 3 × 106 syngeneic T-depleted BM cells (BALB/c nude [H-2d]) in the presence or absence of 5 × 103A20-luc lymphoma cells (day 0). On the following day, mice were intravenously injected with 10 × 106 (n = 7) or 2 × 107 (n = 5) BALB/c-derived anti–third-party Tcm or left untreated (A20 only) (n = 7). (A) Tumor growth was monitored by BLI from day 14 at weekly intervals. (B) Survival curves of the animals from the various treatment groups are shown.
